Figure 1.

Effects of QBX258 treatment on arm volume, bioimpedance (L-Dex), and tonometry measurements. (a) Quantification of arm volumes at baseline, following 4-month treatment with QBX258 (treatment), and 4 months after cessation of treatment (washout). Changes in each patient are shown over time. (b) L-Dex measurements at baseline, following treatment, and following washout period with QBX258. (c) Tonometry measurements at baseline, following treatment, and following washout period with QBX258.